Assessing the utility of the Primary Care PTSD Screen for <i>DSM‐5</i> (PC‐PTSD‐5) as a screening tool among caregivers of hematopoietic stem cell transplantation survivors
Although not an instrument validation study, these findings provide preliminary support for using the PC-PTSD-5 as a succinct, effective screening tool among cancer caregivers in a clinical context.
Authors
- Cole Manschot (ORCID: https://orcid.org/0000-0002-5054-2663)
- Leah E. Walsh (ORCID: https://orcid.org/0000-0001-7081-0306)
- KL Syrjala
- Sophia Smith
- Eric Laber
- Eric Kuhn
- Tamara J. Somers
- Allison J. Applebaum
Institutions
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Duke University (US)
- University of Washington (US)
- Fred Hutch Cancer Center (US)
- National Center for PTSD (US)
- Duke Medical Center (US)
- Duke University Hospital (US)
- Stanford University (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Cancer
- Published
- 2026-02-05
- DOI
- https://doi.org/10.1002/cncr.70285
- Primary Topic
- Cancer survivorship and care
- Type
- article
- Field-Weighted Citation Impact
- 0.00